Evidence map›Paper›PMID 31960146›Full record

ArticleHeart and vessels2020

Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics.

Salaheldin Ahmed, Abdulla Ahmed, Joanna Säleby, Habib Bouzina, Jakob Lundgren, Göran Rådegran

Open access · hybridAbstract read
In one paragraph

Article in Heart and vessels, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Role of the VEGF Family in Coronary Heart Disease.Frontiers in cardiovascular medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Salaheldin AhmedDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden. salaheldin.ahmed@med.lu.se.ORCID http://orcid.org/0000-0001-7086-6262
Abdulla AhmedDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0001-6005-5300
Joanna SälebyDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-3581-4154
Habib BouzinaDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-9956-7060
Jakob LundgrenDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0001-9338-2906
Göran RådegranDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-4919-2771
Lund University · SEValve (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Receptor tyrosine kinases (RTKs) are implicated in cardiovascular growth and remodelling. We aimed to identify the plasma levels of RTKs and related proteins and their association with haemodynamic alterations in heart failure (HF) and related pulmonary hypertension (PH) following heart transplantation (HT). Using proximity extension assay, 28 RTKs and related proteins were analysed in plasma from 20 healthy controls and 26 HF patients before and 1-year after HT. In end-stage HF, out of 28 RTKs, plasma vascular endothelial growth factor-D (VEGF-D) and human epidermal growth factor-4 (HER4) were elevated compared to controls (p < 0.001), but decreased (p < 0.0001) and normalised after HT. Following HT, plasma changes (Δ) of VEGF-D correlated with Δmean pulmonary artery pressure (r

Indexed as

Heart TransplantationHemodynamicsBiomarkersCase-Control StudiesDown-RegulationFemaleHeart FailureHumansMaleMiddle AgedProspective StudiesReceptor, ErbB-4Recovery of FunctionTime FactorsTreatment OutcomeVascular Endothelial Growth Factor DBiomarkersERBB4 protein, humanReceptor, ErbB-4Vascular Endothelial Growth Factor DVEGFD protein, humanHaemodynamicsHeart failureHeart transplantationPulmonary hypertensionReceptor protein-tyrosine kinases

Identifiers

PMID31960146
PMCPMC7198637
OpenAlexW2999155587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.